Abstract
Drug conjugates have become a significant focus of research in the field of targeted medicine for cancer treatments. Peptide-drug conjugates (PDCs), a subset of drug conjugates, are composed of carrier peptides ranging from 5 to 30 amino acid residues, toxic payloads, and linkers that connect the payload to the peptide. PDCs are further broken down into cell-penetrating peptides (CPPs) and cell-targeting peptides (CTPs), each having their own differences in the delivery of cytotoxic payloads. Generally, PDCs as compared to other drug conjugates—like antibody-drug conjugates (ADCs)—have advantages in tumor penetration, ease of synthesis and cost, and reduced off-target effects. Further, as compared to traditional cancer treatments (e.g., chemotherapy and radiation), PDCs have higher specificity for the target cancer with generally less toxic side effects in smaller doses. However, PDCs can have disadvantages such as poor stability and rapid renal clearance due to their smaller size and limited oral bioavailability due to digestion of its peptide structure. Some of these challenges can be overcome with modifications, and despite drawbacks, the intrinsic small size of PDCs with high target specificity still makes them an attractive area of research for cancer treatments.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference72 articles.
1. Current Cancer Epidemiology;Mattiuzzi;J. Epidemiol. Glob. Health,2019
2. Trends in Cancer Mortality Among Black Individuals in the US From 1999 to 2019;Lawrence;JAMA Oncol.,2022
3. Pinheiro, P.S., Callahan, K.E., Gomez, S.L., Marcos-Gragera, R., Cobb, T.R., Roca-Barcelo, A., and Ramirez, A.G. (2017). High cancer mortality for US-born Latinos: Evidence from California and Texas. BMC Cancer, 17.
4. US Spending on Personal Health Care and Public Health, 1996–2013;Dieleman;JAMA,2016
5. Cancer prevention: From 1727 to milestones of the past 100 years;Lippman;Cancer Res.,2009
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献